Robert DeSimone, MD

Highlights

1
Transfusion · 2023
RDRobert DeSimone
PMID: 37387597PMCID: PMC10530070DOIFirst author11 citations
2
Transfusion · 2020
RDRobert DeSimone GEGrant Ellsworth RMRoy M Gulick MCMelissa Cushing
PMID: 33215718PMCID: PMC7753518DOIFirst author23 citations
3
Transfusion · 2020
RDRobert DeSimone MCMelissa Cushing
PMID: 32358816PMCID: PMC9250110DOIFirst author22 citations

63

Completed grants (5)

Co-I
The New York Comprehensive Thalassemia Center - Expanded Network
Centers for Disease Control and Prevention · 2019–2025
No publications yet
NU58DD000005-01 00
Co-I
Recipient Epidemiology and Donor Evaluation Study IV - Pediatric (REDS-IV-P} -Domestic Hubs - Phase 3
National Heart, Lung, and Blood Institute · 2024–2025 · via Columbia University
75N92019D00037
Co-I
Recipient Epidemiology and Donor Evaluation Study IV - Pediatric (REDS-IV-P} -Domestic Hubs - Phase 2
National Heart, Lung, and Blood Institute · 2021–2024 · via Columbia University
75N92019D00037
Co-I
Recipient Epidemiology and Donor Evaluation Study IV - Pediatric (REDS-IV-P} -Domestic Hubs - Phase 2 Budget B
National Heart, Lung, and Blood Institute · 2021–2024 · via Columbia University
75N92019D00037
Co-I
REDS-IV-P Domestic Hubs
National Heart, Lung, and Blood Institute · 2019–2022 · via Columbia University
75N92019D00037

2

Completed & closed trials (2)

PI
Characterizing the Complications Associated with Therapeutic Blood Transfusion for Hemoglobinopathies
Centers for Disease Control & Prevention · IRB STUDY CLOSURE (as of 2026)
PI
Qualification of COVID-19 Convalescent Plasma Donors
Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2022)